Hogan undergoes additional cancer treatment
Gov. Larry Hogan was back in Baltimore on Monday undergoing chemotherapy treatment. The treatment at the University of Maryland Medical Center is part of ongoing maintenance following a highly public battle with an aggressive form of non-Hodgkin Lymphoma, according to Matt Clark, a Hogan spokesman. Clark confirmed the treatment in response to questions from a […]
In Fox interview, Hogan talks about cancer, recovery
In his first national television interview Maryland Gov. Larry Hogan discussed cancer, treatment and recovery on “Fox News Sunday” with Chris Wallace. The interview, which was taped a week before it aired, focused on Hogan’s illness. He was diagnosed with Non-Hodgkin Lymphoma in June, five months after he was sworn in as governor. Hogan said […]
Maryland governor completes chemotherapy
ANNAPOLIS — Gov. Larry Hogan has finished his final round of chemotherapy. Hogan announced Tuesday on his Facebook page that he had completed his sixth round of treatment at the University of Maryland Medical Center. The Republican governor says over the last four months, he has undergone 30 days of 24-hour chemotherapy. He also says […]
Hogan responds to ‘nasty’ columnist
Gov. Larry Hogan Monday responded to a columnist who branded the Republican as "Mr. Nasty."
Md. Gov. Hogan out of hospital after first round of chemo
ANNAPOLIS — Maryland Gov. Larry Hogan is out of the hospital and back at work after his first round of chemotherapy for an aggressive form of cancer. Hogan posted messages on social media Thursday saying, “It feels great to be back in Annapolis!” He says he spent the morning catching up with his staff and […]
Gov. Hogan feeling ‘strong’ during chemotherapy
ANNAPOLIS — Maryland Gov. Larry Hogan says after 60 hours of chemotherapy treatments for an aggressive form of cancer he’s feeling “healthy and strong.” In a posting on his Facebook page Monday night, the governor says he is “doing great.” Hogan announced last week that he’s been diagnosed with an advanced stage of non-Hodgkin’s lymphoma. […]